Prospective Study of FMT for Acute Intestinal GVHD After Allo-HSCT

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
Acute intestinal GVHD is the main cause of death after allo-HSCT, and FMT is a new treatment method for this disease. In this prospective study, the investigators will recruit intestinal GVHD patients to demonstrate the efficacy and safety of FMT.
Epistemonikos ID: 297c4405cb5881db6134c80da1c96025a0ec3659
First added on: May 08, 2024